Zhitong Finance App News, McPharmaceutical-B (02335.HK) announced that the pre-clinical and phase I clinical data of MT200605, an injectable neuroprotective candidate for the treatment of acute ischemic stroke (AIS) independently developed by the Group, has been accepted to present an oral report at the 18th World Stroke Congress (WSC 2026) in 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.